Sun Pharmaceutical Industries Limited : Sun Pharma to announce third quarter results on February 13, 2014

Sun Pharmaceutical Industries Ltd.

17/B, Mahal Industrial Estate, Mahakali Caves Road,
Andheri (East), Mumbai 400 093 India
Tel.: [phone]
Fax.: [phone]

FOR IMMEDIATE RELEASE Sun Pharma to announce third quarter results on February 13, 2014

January 29, 2014, Mumbai: On February 13, 2014, Sun Pharma will announce results for the third quarter & nine month ending December 31, 2013. These results will also be available on the Company website, www.sunpharma.com.

Earnings call (07.00 pm IST, February 13, 2014)

The Company will conduct an hour long call at 07.00 pm IST on February 13, 2014 where senior management will discuss the Company's performance and answer questions from participants. To participate in this conference call, please dial the numbers provided below five to ten minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call. You can also hear the call via an audio webcast, details of which will be announced later on the Company website, www.sunpharma.com. A transcript of this conference call will also be available on the website.

Summary of events

Event	Date and time	Telephone number/ website
Earnings release	February 13, 2014	www.sunpharma.com
Earnings conference call	07.00 pm IST, February 13, 2014	Primary Number : [phone] Secondary Number : [phone] Via audio webcast, details of which will be made available on www.sunpharma.com.
Replay of conference call	February 14, 2014 to February 21, 2014	India: [phone]. ID: #786742 Via audio webcast playback, details of which will be made available on www.sunpharma.com.

About Sun Pharmaceutical Industries Ltd.

Established in 1983, listed since 1994 and headquartered in India, Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) is an international specialty pharmaceutical company with over 72% sales from global markets. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in US, India and several other markets across the world. For the year ending March 2013, overall revenues were at US$2.1 billion, of which US contributed US$1.1 billion. In India, the company is a leader in niche therapy areas of psychiatry, neurology, cardiology, nephrology, gastroenterology, orthopedics and ophthalmology. The company has strong skills in product development, process chemistry, and manufacturing of complex dosage forms. More information about the company can be found at www.sunpharma.com.

Registered Office : SPARC, Tandalja, Vadodara - 390 020. India
Corporate Office : Acme Plaza, Andheri - Kurla Road, Andheri (East), Mumbai - 400 059. India

Sun Pharmaceutical Industries Ltd.

17/B, Mahal Industrial Estate, Mahakali Caves Road,
Andheri (East), Mumbai 400 093 India
Tel.: [phone]
Fax.: [phone]

Contacts

Nimish Desai Mira Desai

Tel [phone], Xtn 5717 Tel [phone], Xtn 5606

Tel Direct [phone] Tel Direct [phone]

Mobile [phone] Mobile [phone]

E mail [e-mail] mail [e-mail]

Registered Office : SPARC, Tandalja, Vadodara - 390 020. India
Corporate Office : Acme Plaza, Andheri - Kurla Road, Andheri (East), Mumbai - 400 059. India